U.S. Markets closed

Iconix Brand Group, Inc. (ICON)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
5.38+0.01 (+0.19%)
At close: 4:00PM EDT
People also watch
SHOOGIIIWWWHIBBPVH
Full screen
Previous Close5.37
Open5.35
Bid5.20 x 200
Ask10.00 x 100
Day's Range5.32 - 5.42
52 Week Range4.79 - 10.80
Volume302,339
Avg. Volume524,312
Market Cap307.15M
Beta1.28
PE Ratio (TTM)-1.24
EPS (TTM)-4.34
Earnings DateNov 6, 2017 - Nov 10, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.13
Trade prices are not sourced from all markets
  • Barrons.com8 days ago

    [$$] 4 Buys in a Watchful Market

    Eli Lilly • LLY-NYSE Long-Term Buy • Price $82.17 on Sept. 12 by Hilliard Lyons At the European Society for Medical Oncology Annual Congress, Lilly presented strong data from a key trial on its cancer drug Abemaciclib. As a reminder to investors, while cross-trial comparisons are difficult to make, the presentation provided physicians and investors the best opportunity to compare Abemaciclib to the other CDK4/6 inhibitors, and we think it can take some market share from competitors in this niche.

  • PR Newswire12 days ago

    Iconix Brand Group to Present at CL King's Best Ideas Conference 2017

    NEW YORK , Sept. 11, 2017 /PRNewswire/ -- Iconix Brand Group, Inc. (Nasdaq: ICON) ("Iconix" or the "Company"), today announced that its Chief Financial Officer, Dave Jones is scheduled ...

  • Why Iconix Brand Group Inc. Stock Lost 16% in August
    Motley Fool12 days ago

    Why Iconix Brand Group Inc. Stock Lost 16% in August

    The consumer-products specialist surprised investors with weak second-quarter results.